pre-IPO PHARMA

COMPANY OVERVIEW

GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.


LOCATION

  • Toulouse, , France

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.gamamabs.com/


    CAREER WEBSITE

    https://www.gamamabs.com/news/recruitment/


    SOCIAL MEDIA


    INVESTORS

    alto-invest biodiscovery-4 innobio irdinov ixo-private-equity


    PRESS RELEASES


    May 4, 2021

    Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target


    Sep 4, 2014

    GamaMabs Pharma Announces Two Scientific Communications on Its AMHR2 Project


    For More Press Releases


    Google Analytics Alternative